GRC 27864 First in Man, Single Ascending Dose Study in Healthy Volunteers

NCT02179645 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: GRC 27864
DRUG: Celecoxib
DRUG: Placebo

Sponsor

Glenmark Pharmaceuticals Ltd. India

Collaborators

[object Object]